Lymphomas: From Mechanisms to Therapeutic Approaches

Dear Colleagues,

We are facing a revolution in lymphoma research, with novel approaches ranging from targeted therapies to cellular therapies like CAR T-cell therapy.  The outcomes of patients are better in terms of prolonged overall survival and progression-free survival while maintaining an adequate quality of life. This would not be possible without in vitro and in vivo research models of lymphomas and phase I/II clinical trials pioneering a personalized medicine approach within hematology, where one size does not fit all. We are witnessing how the extreme efforts of experts of a multidisciplinary community, ranging from basic medicine to fruitful phase III randomized clinical trials, at every stage of lymphoma treatment can make a difference. As lymphomas are orphan diseases, breakthrough developments in novel drugs by regulatory agencies are the ultimate goal. I invite you to submit preclinical or early clinical data to try to make a difference, not only to the wealth of research, but for individuals living with lymphoma.

Dr. Delfa Radić-Krišto
Dr. Vibor Milunović
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.